Prenatal naltrexone facilitates male sexual behavior in the rat

Edna Cohen*, Gilmor Keshet, Yehuda Shavit, Marta Weinstock

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

The involvement of endogenous opiates in the differentiation of sexual behavior was tested by exposing rat fetuses to continuous naltrexone during the last 9 days of gestation. Time-mated female rats received oral naltrexone, 40 mg/kg/day, via their drinking water, from gestational day 13 until parturition. Early motor development, measured by swimming ability in 7-, 9-, and 11-day-old offspring of the treated dams, was unaffected by prenatal naltrexone. Adult male offspring were given three tests of male sexual behavior, then castrated, primed with ovarian hormones, and given two tests of feminine receptivity (lordosis quotient). Prenatal naltrexone facilitated masculine behavior and suppressed feminine receptivity: latencies to first mount and to ejaculation were shorter, mount rate was higher, and lordosis quotient was lower in naltrexone-treated rats, compared with control animals. These findings implicate endogenous opiates in prenatal organization of sex-specific behavioral dispositions.

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalPharmacology Biochemistry and Behavior
Volume54
Issue number1
DOIs
StatePublished - May 1996

Keywords

  • Defeminization
  • Endogenous opiates
  • Masculinization
  • Oral naltrexone
  • Prenatal development
  • Sexual differentiation

Fingerprint

Dive into the research topics of 'Prenatal naltrexone facilitates male sexual behavior in the rat'. Together they form a unique fingerprint.

Cite this